Buy Lumakras (sotorasib) online

Description

Buy Lumakras (sotorasib) online

What is Lumakras (sotorasib) for?
Lumakras (sotorasib) is a prescription medicine used to treat adult patients with non-small cell lung cancer (NSCLC):[1]

that has spread to other parts of the body or cannot be removed by surgery, and
whose tumor has an abnormal KRAS G12C gene, and
who have received at least one prior systemic treatment for their cancer.
It is available in tablet form containing 120 mg sotorasib.[1]

How does Lumakras (sotorasib) work?
13% of patients with NSCLC have an abnormal KRAS G12C gene. KRAS is an oncogene, a gene that is a mutated (changed) form of a gene involved in normal cell growth. It produces the mutant form of the KRAS protein, which drives the development of lung and other cancer.[2,3]

Lumakras contains the active ingredient sotorasib, which is designed to inactivate the mutated protein. Thereby it can block tumor growth and slow down the disease.[2,3]

It is not a chemotherapy, immunotherapy, or tyrosine kinase inhibitor. It’s an oral inhibitor designed specifically for patients with a KRAS G12C mutation.[2,3]

Where has Lumakras (sotorasib) been approved?
Lumakras (sotorasib) was approved for the treatment of people with KRAS G12C-mutated advanced NSCLC by:

Buy Lumakras (sotorasib) online

The Food and Drug Administration (FDA), USA on May 28, 2021.[4]
Lumakras (sotorasib) was granted Breakthrough Therapy Designation in the U.S. and China.[4]

It is also being studied in multiple other solid tumors.[4]

Please note that this medicine may have also been approved in other regions than the ones we’ve listed. If you have a question about its approval in a specific country feel free to contact our support team.

How is Lumakras (sotorasib) taken?
The standard dosage is:[1]

960 mg (eight 120 mg tablets) taken orally once daily
Take the tablets at the same time each day with or without food. Take this medicine until the disease progresses or unacceptable side effects occur.[1]

If vomiting occurs after taking the tablets, do not take an additional dose. Take the next dose as prescribed the next day.[1]

If adverse reactions occur, the dose should be reduced.[1]

Avoid taking this medicine with acid-reducing agents, including Proton Pump Inhibitor (PPI) medicines or H2 blockers. If you take an antacid medicine, take Lumakras either 4 hours before or 10 hours after the antacid.[1]

Complete information about Lumakras (sotorasib) dosage (modifications) and administration can be found in the official prescribing information listed in our references section.[1]

Note: Please consult with your treating doctor for personalised dosing.

Are there any known adverse reactions or side effects of Lumakras (sotorasib)?
Common adverse reactions
The most common side effects ( ≥5% of patients) listed in the prescribing information include:[1]

diarrhea
muscle or bone pain
nausea
tiredness
liver problems
cough
changes in liver function tests
changes in certain other blood tests
Serious adverse reactions
The serious adverse reactions listed in the prescribing information include:[1]

Buy Lumakras (sotorasib) online

Liver problems
Lung or breathing problems
Use in a specific population
It is not known if Lumakras will harm your unborn baby. It is not known if Lumakras passes into your breast milk. Do not breastfeed during treatment, and for 1 week after the final dose.[1]

Lumakras (Sotorasib)

What is Lumakras used for?

Lumakras for non-small cell lung cancer (NSCLC)

Lumakras KRAS G12C mutation treatment

Lumakras for KRAS-positive cancer

Lumakras 120mg dosage

Buy Lumakras online

Lumakras treatment for lung cancer

Lumakras pill

Lumakras side effects

Usage and Effectiveness:
Lumakras for NSCLC treatment

How does Lumakras work for KRAS G12C mutation?

Lumakras efficacy in KRAS-mutated cancer

Lumakras for advanced lung cancer

Lumakras effectiveness in treating NSCLC

Lumakras for metastatic NSCLC

Lumakras for lung cancer with KRAS mutation

How effective is Lumakras for KRAS-positive lung cancer?

Lumakras and KRAS G12C inhibition

Lumakras for late-stage non-small cell lung cancer

Side Effects and Safety:
Lumakras side effects

Common side effects of Lumakras

Serious side effects of Lumakras

Lumakras and liver toxicity

Lumakras and gastrointestinal issues

Lumakras and skin rash

Lumakras and fatigue

Lumakras and diarrhea

Lumakras and heart issues

Lumakras and drug interactions

Dosage and Administration:
Lumakras 120mg dosage

How to take Lumakras

Lumakras dosage for lung cancer

Lumakras treatment schedule

Lumakras daily dosage

Lumakras and food intake

How often to take Lumakras for NSCLC

Lumakras pill dosage instructions

Lumakras in combination with other therapies

Lumakras administration for KRAS G12C-positive lung cancer

Cost and Insurance:
Lumakras cost without insurance

Lumakras price per month

How much does Lumakras cost?

Lumakras insurance coverage

Lumakras financial assistance programs

Lumakras co-pay assistance

Lumakras pricing without coverage

How to save on Lumakras

Lumakras and out-of-pocket costs

Lumakras for uninsured patients

Comparisons with Other Treatments:
Lumakras vs chemotherapy for lung cancer

Lumakras vs Keytruda

Lumakras vs other targeted therapies for NSCLC

Lumakras vs immunotherapy for NSCLC

Lumakras vs other KRAS inhibitors

Lumakras vs osimertinib (Tagrisso)

Lumakras vs traditional cancer treatments

Lumakras vs other KRAS G12C inhibitors

Lumakras vs combination therapies for lung cancer

Lumakras vs chemotherapy for KRAS-positive cancers

Patient Experiences and Testimonials:
Lumakras patient reviews

Does Lumakras work for lung cancer?

Lumakras success stories

Lumakras effectiveness for advanced NSCLC

Lumakras side effects patient feedback

Patient experiences with Lumakras for KRAS mutation

Lumakras for metastatic NSCLC patient testimonials

Lumakras for KRAS-positive lung cancer survival rate

Lumakras success in clinical trials

Patient stories using Lumakras for late-stage lung cancer

Precautions and Warnings:
Lumakras precautions

Who should not take Lumakras?

Lumakras and pregnancy

Lumakras and liver function

Lumakras and kidney issues

Lumakras and lung cancer complications

Lumakras contraindications

Lumakras and drug interactions

Lumakras and risk of secondary cancers

Lumakras and blood clotting disorders